Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

So monikers like “Step Inna It”, “Hopscotch” and “Tippy” — all coined because of his gait — became dreaded nicknames for the ...

BRIDGEWATER, NJ, USA I March 14, 2025 I Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug ...

A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children's Hospital Los Angeles, shows evidence of dysfunction of the blood-brain barrier and ...